Feb 02, 2023 / 10:00PM GMT
Tracy Curley - iSpecimen Inc. - CEO
Hi. My name is Tracy Curley. I'm the CEO of iSpecimen Inc. We are a technology company in the life science space, and we connect researchers to suppliers of biospecimens, human biospecimens with our proprietary marketplace platform. And so today, I'm going to share with you our investor presentation.
Just as a reminder, we have some forward-looking statements. I'm not going to read through this, but we are a public company, so these all do apply for us.
Just a few highlights for investors regarding iSpecimen. We're an early-stage opportunity with a first-mover advantage because of our proprietary marketplace platform. There's no other company in our industry that actually has this platform.
We're unique in that we have a two-sided marketplace, and we're disrupting the biospecimen procurement process. We have strong revenue growth over the last six years. Our expectation is we're going to continue to grow. And we also have a growing data asset that we haven't monetized yet, that we're really excited about as we build out our platform further
iSpecimen Inc at SRAX Sequire Biotechnology Conference (Virtual) Transcript
Feb 03, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers